AllianceRx Walgreens Prime Launches Digital Clinical Tools

As the COVID-19 pandemic wears on, it’s more important than ever for people to have the ability to perform needed actions from home. To help with this, AllianceRx Walgreens Prime has released some digital clinical assessments that allow people with certain illnesses to manage their conditions online and remain adherent to therapy.

The assessments are available for people with chronic inflammatory disease, cystic fibrosis, idiopathic pulmonary fibrosis, lipid and blood disorders, multiple sclerosis and organ transplants. Asked how the company decided upon those conditions, James Adams, chief information officer at AllianceRx Walgreens Prime, says that it “took a strategic approach” that “was based on patient volume, diseases and conditions with lower risk, as well as stability of patients. The chronic inflammatory disease (CID) space was our first program to implement digitally with patients already established on therapy. This included patients with conditions such as rheumatoid arthritis, psoriasis, atopic dermatitis, ulcerative colitis, ankylosing spondylitis and others.”

AIS Health Staff

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/09/Specialty_article_Anthem_Launches_Voluntary.jpg
September 9

Anthem Launches Voluntary Oncology Dose Reduction Program

Read More
https://www.mmitnetwork.com/wp-content/uploads/2021/09/Specialty_Pharmacy_article_Home_Infusion_Policies.jpg
September 9

Legislation Seeks to Change Medicare Home Infusion Policies

Read More
https://www.mmitnetwork.com/wp-content/uploads/2021/09/Specialty_Pharmacy_article_Specialty_Trend.jpg
September 9

Specialty Trend Increase Slows; Biosimilars Are Having Impact

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today